Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%

Follow WST

Alert me

Market cap: $27.0B
P/E: 48.7×
Fwd P/E: 37.3×
Dividend yield: 0.23%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	16.94%	16.85%	19.13%	19.09%
Piotroski F-Score Full definition →		7	8	8	9
ROA Full definition →		12.64%	12.48%	14.05%	14.07%
ROIC Full definition →		13.99%	14.13%	15.32%	15.42%
Return on Tangible Assets Full definition →		16.79%	16.19%	19.01%	19.80%
Average Days of Receivables Full definition →		75.59	68.20	77.69	78.12
Free Cash Flow per Share Full definition →		5.25	6.49	6.36	6.17
Free Cash Flow Full definition →		379.10	468.90	458.00	436.90
Capital Expenditures Full definition →		(314.70)	(285.90)	(257.30)	(225.30)
Other line items
Cash ROIC Full definition →		9.76%	11.24%	12.33%	12.04%
Accounts Receivable Turnover Full definition →		5.25	5.46	5.24	5.14
Accounts Payable Turnover Full definition →		8.10	7.99	8.54	8.55
Inventory Turnover Full definition →		4.63	4.80	4.88	4.84
Average Days of Payables Full definition →		48.02	47.00	44.87	43.86
Days of Inventory on Hand Full definition →		82.23	82.24	80.49	77.65
Tax Rate Full definition →		(0.21)	(0.20)	(0.21)	(0.21)
Research and Development Expense of Revenue Full definition →		2.35%	2.42%	2.29%	2.24%
Selling, General and Administrative Expense of Revenue Full definition →		12.32%	12.80%	12.58%	12.83%
Share Based Compensation of Revenue Full definition →		0.71%	0.77%	0.90%	0.98%
Interest Coverage Full definition →		(5,879.00)	1,169.80	327.50	151.20
Operating CF/Net income Full definition →		1.41	1.53	1.32	1.17
Depreciation/Fixed assets Full definition →		0.09	0.10	0.10	0.11
Capex/Depreciation Full definition →		(1.91)	(1.67)	(1.46)	(1.24)
Revenue per Share Full definition →		41.80	42.52	44.74	46.99
Operating CF per Share Full definition →		9.61	10.44	9.93	9.35
Capex per Share Full definition →		(4.36)	(3.95)	(3.57)	(3.18)
Capex to Sales Full definition →		0.10	0.09	0.08	0.07

Show all line items

Columns are period end dates

Stockrow Weekly